BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $951,283 | -10.0% | 134,362 | +6.0% | 0.00% | 0.0% |
| Q1 2023 | $1,056,670 | +181.0% | 126,699 | +256.2% | 0.00% | +100.0% |
| Q2 2022 | $376,000 | -97.9% | 35,574 | -96.7% | 0.00% | -97.0% |
| Q1 2022 | $17,656,000 | +849.2% | 1,085,846 | +493.7% | 0.03% | +266.7% |
| Q1 2021 | $1,860,000 | +678.2% | 182,905 | +263.8% | 0.01% | +350.0% |
| Q2 2020 | $239,000 | +67.1% | 50,277 | -29.8% | 0.00% | +100.0% |
| Q1 2020 | $143,000 | -94.9% | 71,660 | -67.2% | 0.00% | -97.6% |
| Q2 2014 | $2,785,000 | – | 218,413 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |